Insulet announced today that it is rolling out new algorithm enhancements for its Omnipod 5 automated insulin delivery system ...

In early June 2026, Insulet began rolling out FDA-cleared algorithm enhancements to its Omnipod 5 Automated Insulin Delivery System in the U.S., adding a 100 mg/dL target option and new compatibility ...

Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.

Insulet Corporation (NASDAQ:PODD) is one of the oversold stocks to buy right now. On June 3, Insulet launched significant ...

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

(RTTNews) - Insulet (PODD) announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. The new 100 mg/dL Target Glucose expands ...

Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range Insulet-led sessions will ...

Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.

PODD secured FDA clearance for Omnipod 5 enhancements, including a 100 mg/dL Target Glucose option. PODD's updated algorithm aims to improve automated insulin delivery and reduce interruptions for ...